Search by Medical Condition

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Clinical Trials for Myocardial Infarction

• Henagliflozin Reducing Infarct Size After Priamry PCI in Patients With ST Segment Elevation Myocardial Infarction
• Dapagliflozin in STEMI Randomized Clinical Trial
• IRI-EXPLORE: A Study to Test Whether BI 765845 Helps People Who Have Had a Heart Attack
• ARTEMIS - A Research Study to Look at How Ziltivekimab Works Compared to Placebo in People With a Heart Attack
• Evolocumab in STEMI
• Century Clot-Guided Prophylactic Rivaroxaban for Post STEMI Complicating Left Ventricular Thrombus
• A Study to Evaluate Accuracy and Validity of the Chang Gung ECG Abnormality Detection Software
• Comparison Between the Effects of High Doses Statin on Ventricular Remodeling in STEMI Patients
• Anti-CoagulaTion on Left Ventricular Thrombus After ST Segment Elevation Myocardial Infarction
• Effect of Nivolumab vs Placebo in Patients With Acute Myocardial Infarction: A Randomized Clinical Trial
• Safety and Efficacy Study of Dutogliptin in Co-administration With Filgrastim in Early Recovery Post-myocardial Infarction
• Advanced Cardiovascular Imaging of the Systemic Effects of Inflammasome Activation
• Anticoagulation in Post MI LV Thrombus Trial in Nepal
• Prasugrel Or Ticagrelor De-escalation in NSTE-ACS
• DAPAgliflozine to Attenuate Cardiac RemOdeling afTEr aCuTe myOcardial Infarction
• Effect of INtravenous FERRic Carboxymaltose Onmortality and Cardiovascular Morbidity, and Quality of Life in Iron Deficient Patients With Recent Myocardial infarCTion
• Efficacy and Safety of Low Dose Rivaroxaban in Patients With Anterior Myocardial Infarction
• Colchicine in Patients Undergoing Coronary Artery Bypass Grafting After Acute Coronary Syndrome
• PRasugrEl Monotherapy Following prImary percUtaneous Coronary Intervention for ST-elevation Myocardial Infarction
• Effect of Colchicine on MMP-9, NOX2, and TGF-β1 in Myocardial Infarct
• Rivaroxaban vErsus Warfarin for Antithrombotic TheRapy in Patients With LeFt Ventricular Thrombus After Acute STEMI
• Reversal of Complete Heart Block With Aminophylline in Inferior Wall Myocardial Infarction Patients
• Prevention Of Sudden Cardiac Death After Myocardial Infarction by Defibrillator Implantation
• 1-Year Follow-up of OPTIMA-5
• HOST - DAPT Duration According the Bleeding Risk
• Effect of Very Early and Rapid Lowering Cholesterol With Evolocumab on Left Ventricular Remodeling in Patients With Anterior STEMI Undergoing Primary PCI
• Cardiac MRI-guided Deferiprone Therapy for Acute Myocardial Infarction Patients
• Pirfenidone Treat Myocardial Fibrosis After Acute Myocardial Infarction
• The Efficacy and Safety of Ketotifen in Primary PCI Patients With STEMI
• Comparison Of Reduced DAPT Followed by P2Y12 Inhibitor Monotherapy With Prasugrel vs stAndard Regimen in STEMI Patients
• Safety and Efficacy Study of Thymosin Beta 4 in Patients With Acute Myocardial Infarction.Infarction
• EVALUATION OF LOW DOSE COLCHICINE AND TICAGRELOR IN PREVENTION OF ISCHEMIC STROKE IN PATIENTS WITH STROKE DUE TO ATHEROSCLEROSIS
• Intervention of Suxiao Jiuxin Pill on Instability of Vulnerable Plaque in Acute Myocardial Infarction
• Pulse Glucocorticoid Therapy in Patients With ST-Segment Elevation Myocardial Infarction
• Impact of DApagliflozin on Cardiac Function Following Anterior Myocardial Infarction in Non-Diabetic Patients
• A Study to Learn How the Study Treatment Asundexian Moves Into, Through and Out of the Body, How it Works, How Safe it is, and How it Affects the Body in Participants With Mild or Moderate Reduction of Liver Function Compared to Participants With No
• Targeting Investigation and Treatment in Patients With Type 2 Myocardial Infarction
• Efficacy and Safety of an Early Phase Single-bolus r-SAK for Acute Myocardial Infarction
• A Study of NP-011 in Healthy Volunteers
• Ticagrelor-based De-escalation of Dual Antiplatelet Therapy After Coronary Artery Bypass Grafting
• Thrombolysis in STEMI Patients Compared With pPCI on Recanalization Time in the Context of the COVID-19 Outbreak.
• Study to Assess Efficacy and Safety of CDR132L in Patients With Reduced Left Ventricular Ejection Fraction After Myocardial Infarction
• Low-Dose Dobutamine and Single-Dose Tocilizumab in Acute Myocardial Infarction With High Risk of Cardiogenic Shock
• Evaluation of the Effect of SGLT-2 Inhibitors on Cardiac Remodeling in Post Myocardial Infarction Patients
• Efficacy and Safety of OPL-0301 Compared to Placebo in Adults With Post-Myocardial Infarction (MI)
• An Open Study on the Efficacy of Iron Therapy Using iv Iron Relative to Oral Iron for Increasing LV Systolic Function
• Sodium Glucose Co-Transporter 2 (SGLT2) and STEMI
• Impact of Early PCSK9 Inhibitor Treatment on Heart After Acute Myocardium Infarction
• MLC1501 Study Assessing Efficacy in Post STrOke Subjects With mOtor Deficits
• 3D PET Myocardial Blood Flow and Rb82 Infusion Profiles
• EVOLVE-MI: EVOLocumab Very Early After Myocardial Infarction
• Pretreatment With Unfractionated Heparin for ST Elevation Myocardial Infarction
• Combined Antioxidant Therapy Against Myocardial Reperfusion Injury. Phase I Study.
• Rituximab in Patients With ST-elevation Myocardial Infarction
• Optimal Dosage of Ticagrelor in Korean Patients With AMI
• Effect of Colchicine On Left Ventricle Function After Anterior Myocardial Infarction Assessed By Speckle Tracking
• Stratified Medicine of Eplerenone in Acute MI/Injury (StratMed-MINOCA)
• Metformin and Prevention of Cardiovascular Events in Patients With Acute Myocardial Infarction and Prediabetes (MIMET)
• Interleukin-1 Blockade in Acute Myocardial Infarction to Prevent Heart Failure
• Clinical Outcome and Cost-effectiveness of Reduced Noradrenaline by Using a Lower Blood Pressure Target in Patients With Cardiogenic Shock From Acute Myocardial Infarction
• Percutaneous Revascularization in Infarction With Late Presentation and Absence of Viability: Effects on Left Ventricular Remodeling and Contractility
• Ticagrelor Monotherapy After Stenting
• Prognostic Value of Precision Medicine in Patients With MINOCA (PROMISE Trial).
• Differential EFfects of Dual antIplatelet and Dual aNtithrombotic thErapy on Hemostasis in Chronic Coronary Syndrome Patients
• Evaluation of CCR2 in Patients Post Myocardial Infarction
• Direct Oral Anticoagulants for Prevention of lEft ventRIcular Thrombus After Anterior Acute Myocardial InFarction - APERITIF
• Sacubitril/Valsartan Versus Valsartan for Hypertensive Patients With Acute Myocardial Infarction
• The Effect of Dapagliflozin on the Short-term Prognosis of Patients With Acute Myocardial Infarction
• MLC1501 Study Assessing Efficacy in STROke Recovery
• The Effect of Early Administration of Dapagliflozin in STEMI Patients With LV Systolic Dysfunction
• The Protective Effect of Prostaglandin on Coronary Microcirculation and Ventricular Remodeling After Reperfusion Therapy in Acute ST-segment Elevation Myocardial Infarction
• Efficacy of an Early Phase Single Bolus r-SAK for Acute Myocardial Infarction: a Multi-center Randomized Clinical Trial
• EMpagliflozin to PREvent worSening of Left Ventricular Volumes and Systolic Function After Myocardial Infarction
• Adenosine's Effect on STunning Resolution in Acute Myocardial Infarction
• The Impact of Compound Danshen Dropping Pills (CDDP) on the Post-myocardial Infarction Ventricular Remodeling
• Influence of Pelacarsen on Patients After Myocardial Infarction With High Lp(a) Values (PEMILA)
• Effect of Statin Preloading in STEMI in Improving PCI Outcomes
• Effect of Levosimendan on Left Ventricular Systolic Function and Heart Failure After PCI in Patients With Acute Anterior Myocardial Infarction
• Effect of Shexiang Tongxin Dropping Pills on Microcirculation in Patients With AMI
• Evolocumab or Normal Strategies to Reach LDL Objectives in Acute Myocardial Infarction Upbound to PCI
• Comparison of Atorvastatin and Pitavastatin on the Effect of HbA1c in AMI Patients With Abnormal Glucose Metabolism
• Evaluation of Myocardial Reperfusion After Primary PCI in Patients With High Platelet Reactivity Treated by Cangrelor or Not
• Cardioprotective Effect of Dexmedetomidine in Patients With ST-segment Elevation Myocardial Infarction
• The Effects of Sacubitril-Valsartan vs Enalapril on Left Ventricular Remodeling in ST-elevation Myocardial Infarction
• Prevention of Acute Kidney Injury in Patients With NSTEMI
• Peri-treatment of SGLT-2 Inhibitor on Myocardial Infarct Size and Remodeling Index in Patients With Acute Myocardial Infarction and High Risk of Heart Failure Undergoing Percutaneous Coronary Intervention
• Rivaroxaban in Type 2 Myocardial Infarctions
• Evaluation in STEMI Patients Using FDY-5301
• Effect of Nicorandil on Cardiac Sympathetic Nerve for the Patients of Acute ST Segment Elevation Myocardial Infarction
• A Phase 2B Study of RUC-4 in Subjects With ST-elevation MI
• Study of Long-Term Efficacy and Safety of LIB003 in CVD or High Risk for CVD Patients Needing Further LDL-C Reduction
• Study of Roxadustat in the Treatment of Acute Myocardial Infarction
• Beta Blocker De-prescription Following Coronary Artery Bypass Graft Surgery (BEEFBURGER Trial).
• Effect of Dapagliflozin on LV Remodeling Post AMI
• Long-term Beta-blocker Therapy After Acute Myocardial Infarction
• Ticagrelor De-escalation Strategy in East Asian Patients With AMI
• Effect of Upstream Treatment With High Intensity Statin on the Outcomes of STMI Patients Treated With PPCI
• Evaluation of a Modified Anti-Platelet Therapy Associated With Low-dose DES Firehawk in Acute Myocardial Infarction Patients Treated With Complete Revascularization Strategy
• Platelet Inhibition With Ticagrelor 60 mg Versus Ticagrelor 90 mg in Elderly Patients With ACS
• Acute Myocardial Infarction and Unstable Angina Patients With PCSK9 Inhibitor Usage Study
• Dapagliflozin Effects on Mayor Adverse Cardiovascular Events in Patients With Acute Myocardial Infarction (DAPA-AMI)
• Role of Alprazolam in the Management of Acute Coronary Syndrome
• Ezetimibe Utilization Early After Acute Myocardial Infarction, "EzAMI Trial"
• Study on the Clinical and Mechanism of Wenyang Huoxue Decoction in Treating Heart Failure After Myocardial Infarction
• Dual Therapy With Dabigatran/Ticagrelor Versus Dual Therapy With Dabigatran/Clopidogrel in ACS Patients With Indication for NOAC Undergoing PCI
• Treatment of Slow-flow After Primary Percutaneous Coronary Intervention With Flow-mediated Hyperemia
• Open-label Study of Neuraminidase Inhibitor Treatment in STEMI Patients
• Clinical and Metabonomics Study on the Treatment of Heart Failure After Myocardial Infarction With Modified Wenxin Decoction
• Clinical Efficacy and sAfety of Intravenous Infusion of Nicorandil During Primary Percutaneous Coronary Intervention
• VerifyNow to Optimise Platelet Inhibition in Coronary Acute Syndrome
• Open-label Extension Study for CLCZ696G2301 (PARADISE-MI)
• The EPIVER Randomized Controlled Trial
• Effect of Low-dose Intracoronary Reteplase on Myocardial Infarct Size During Primary Percutaneous Coronary Intervention
• 3 Months Versus 12 Months Dual Antiplatelet Therapy After Drug-eluting Stent Implantation in STEMI
• Dapagliflozin Effects on Cardiovascular Events in Patients With an Acute Heart Attack
• Personalised Risk scOre For Implantation of Defibrillators in Patients With Reduced LVEF≤35% and a Low Risk for Sudden Cardiac Death
• Personalised Risk scOre For Implantation of Defibrillators in Patients With Preserved LVEF>35% and a High Risk for Sudden Cardiac Death
• EMPACT-MI: A Study to Test Whether Empagliflozin Can Lower the Risk of Heart Failure and Death in People Who Had a Heart Attack (Myocardial Infarction)
• Low Dose Rosuvastatin Plus Ezetimibe Versus High-dose Rosuvastatin in AMI
• Randomized Evaluation of Shenfu Injection to Reduce Myocardial Injury
• ANalgesic Efficacy and Safety of MOrphiNe Versus Methoxyflurane in Patients With Acute Myocardial Infarction
• Study to Evaluate the Effect on Parameters of Systemic Inflammation and Disease Outcomes and Safety of RPH-104 in Subjects With Acute ST-elevation Myocardial Infarction
• Periprocedural Continuation Versus Interruption of Oral Anticoagulant Drugs During Transcatheter Aortic Valve Implantation (POPular PAUSE TAVI)
• What is the Optimal Antithrombotic Strategy in Patients Presenting With Acute Coronary Syndrome Having Atrial Fibrillation With Indication for Anticoagulants?
• Bone Marrow Mesenchymal Stem Cells Transfer in Patients With ST-segment Elevation Myocardial Infarction
• COLchicine to Prevent Sympathetic Denervation After an Acute Myocardial Infarction
• Potassium-Competitive Acid Blocker Versus pROton-Pump Inhibitor for GastroproTECTion Strategies In Patients at High Gastro-Intestinal Bleeding Risk Receiving Antithrombotic Therapy
• Cilostazol and Endothelial Progenitor Cell
• Effect of Hydration Guided by Vigileo on the Prevention of CIN After Direct PCI for Patients With AMI
• Efficacy and Safety of Individualized P2Y12 Receptor Antagonists Treatment Based on Agregometry Versus Fixed Dose Regimen in Patients After Acute Myocardial Infarction
• Dapagliflozin and Effect on Cardiovascular Events in Acute Heart Failure -Thrombolysis in Myocardial Infarction 68 (DAPA ACT HF-TIMI 68)
• Assessment of the Effects of Long-term Lipid-lowering Therapy in Patients With Primary STEMI or NSTEMI
• Early Treatment of ARNI on Myocardial Remodeling and Progress
• Safety Evaluation of Intracoronary Infusion of Extracellular Vesicles in Patients With AMI
• Study to Gather Information About the Proper Dosing and Safety of the Oral FXIa Inhibitor BAY 2433334 in Patients Following an Acute Heart Attack
• A Phase 2 Open Label Study to Assess the PK/PD Properties of RUC-4 in Patients With a ST-elevation Myocardial Infarction
• Management of Anticoagulant Therapy Monitored by an Implantable Device With Telecardiology in Patients With Acute Coronary Syndrome Associated With de Novo Atrial Fibrillation Arrhythmia
• SP16 Inflammatory Response Inhibition Trial
• Effect of Colchicine in Patients With Myocardial Infarction
• SONOthrombolysis in Patients With an ST-segment Elevation Myocardial Infarction With fibrinoLYSIS (SONOSTEMI-LYSIS) Trial
• Bivalirudin in Late PCI for Oatients With STEMI
• Ticagrelor in Remote Ischemic Preconditioning Study
• Early rhBNP on Myocardial Work in Patients With STEMI
• Angiotensin-Neprilysin Inhibition in Diastolic Dysfunction After AMI
• Colchicine Prevents Myocardial Injury After Non-Cardiac Surgery Pilot Study
• Personalized Vs. Standard Duration of Dual Antiplatelet Therapy and New-generation Polymer-Free vs- Biodegradable-Polymer DES
• ARomatherapy for Cognitive Trajectory in Chinese After Coronary Artery Bypass Grafting
• Study in Diabetes Mellitus Patients Without Prior Myocardial Infarction or Stroke Undergoing Elective Percutaneous Coronary Intervention.
• Early rhBNP on Myocardial Remodeling and Reperfusion in Patients With STEMI
• Comprehensive Oral Intervention in Patients With AMI
• A Study of Low-dose Intracoronary Thrombolytic Therapy in STEMI (Heart Attack) Patients.
• Efficacy, Safety and Tolerability of ATH3G10 in Patients With ST-elevation Myocardial Infarction
• Iron in Patients With Cardiovascular Disease
• Neuroinflammation After Myocardial Infarction - Imaging Substudy
• Effect of Doxycycline on Cardiac Remodelling in STEMI Patients
• Clinical Study of Cardiomyopeptidin on Postoperative Ischemia-reperfusion Injury in Patients With Primary PCI
• The Role of Sacubitril/Valsartan in Post-acute Myocardial Infarction
• Bivalirudin in Elderly Patients With Acute ST-segment Elevation Myocardial Infarction
• Effect of Evolocumab in Patients at High Cardiovascular Risk Without Prior Myocardial Infarction or Stroke
• Bivalirudin With Prolonged Full Dose Infusion Versus Heparin Alone During Emergency PCI
• Ticagrelor Administered as Standard Tablet or Orodispersible Formulation
• Early Initiation of Low Dose Tirofiban for PPCI in STEMI Patients.
• China Tongxinluo Study for Myocardial Protection in Patients With Acute Myocardial Infarction
• Prevention of Post-STEMI Left Ventricular Thrombus With Optimized Anticoagulant (EARLYmyo-LVT Ⅱ)
• Danish Trial of Beta Blocker Treatment After Myocardial Infarction Without Reduced Ejection Fraction
• Treatment of Post-STEMI Left Ventricular Thrombus With Optimized Anticoagulant
• Early Intracoronary Administration of Fasudil in the Primary PCI of ST-segment-Elevation Myocardial Infarction
• Early Alirocumab to Reduce LDL-C in Myocardial Infarction
• Colchicine in Periprocedural Myocardial Infarction: the Role of Alpha Defensin
• Personalization of Long-Term Antiplatelet Therapy - RAPID EXTEND
• Effects of Acute, Rapid Lowering of LDL Cholesterol With Alirocumab in Patients With STEMI Undergoing Primary PCI
• Firibastat or Ramipril After Acute Myocardial Infarction for Prevention of Left Ventricular Dysfunction
• Clinical Trial in Patients Who Have Suffered a Heart Attack and Who Have Undergone Catheterization Treated With Levosimendan
• Randomized Evaluation of Beta Blocker and ACEI/ARB Treatment in MINOCA Patients - MINOCA-BAT
• Intramyocardial Haemorrhage in Patients With Primary STEMI
• Comparison of Anticoagulation Prolongation vs. no Anticoagulation in STEMI Patients After Primary PCI
• Effect of Dapagliflozin on the Progression From Prediabetes to T2DM in Subjects With Myocardial Infarction
• Chronic Kidney Disease (CKD) Platelet Study
• BEtablocker Treatment After Acute Myocardial Infarction in Patients Without Reduced Left Ventricular Systolic Function
• TREatment With Beta-blockers After myOcardial Infarction withOut Reduced Ejection fracTion"
• Effect of Intravenous Metoprolol Combining RIC on Myocardial Protection in STEMI Patients
• Prolonged Enoxaparin in Primary Percutaneous Coronary Intervention
• The Effects of Sacubitril/Valsartan Compared to Valsartan on LV Remodelling in Asymptomatic LV Systolic Dysfunction After MI
• Dual Antiplatelet Therapy For Shock Patients With Acute Myocardial Infarction
• A Polypill for Secondary Prevention of Ischemic Heart Disease
• Intravenous MSC Therapy on Ischemia-Reperfusion Injury in Patients With Myocardial Infarction
• A Randomized Trial of Rosuvastatin Loading Combined With Early hydrAtion Versus Standard-of-care Medications for the Prevention of CIAKI in Patient With AMI Undergoing Emergency PCI
• Effect of Methotrexate Carried by a Lipid Nanoemulsion on Left Ventricular Remodeling After STEMI
• Doxycycline to Protect Heart Muscle After Heart Attacks
• Beta Blocker Interruption After Uncomplicated Myocardial Infarction
• A Medical Research Study to Evaluate the Effects of ACT-246475 in Adults With Heart Attack
• Study of Dutogliptin in Combination With Filgrastim in Post-Myocardial Infarction
• A Study of Acute Myocardial Infarction Using FDY-5301
• ShorT and OPtimal Duration of Dual AntiPlatelet Therapy-2 Study for the Patients With ACS
• Daily Variability of Platelet Aggregation in Patients With Myocardial Infarction Treated With Prasugrel and Ticagrelor
• 68 Ga-NODAGA-E[c(RGDγK)]2: Positron Emission Tomography Tracer for Imaging of Myocardial Angiogenesis
• China-Administration of Nicorandil Group（CHANGE）
• Prasugrel vs. Ticagrelor on Myocardial Injury in STEMI
• Comparision Between Activated Partial Thromboplastin Time Versus Anti-Xa Activity in Heparin Monitoring
• Optimized Antithrombotic Therapy of Acute Myocardial Infarction With Left Ventricular Mural Thrombus
• Prevention of Coronary Slow Flow or No-Reflow During EPCI in Patients With Acute STEMI
• Prevention of Coronary Slow Flow or No-Reflow During PPCI in Patients With Acute STEMI
• Vitamin D Deficiency Treatment Outcomes After Non-ST-Segment Elevation Myocardial Infarction
• Cardiovascular Clinical Project to Evaluate the Regenerative Capacity of CardioCell in Patients With Acute Myocardial Infarction (AMI)
• Safety and Efficacy Study of Gene Therapy for Acute Myocardial Infarction in Korea
• The Effect of Opioids on P2Y12 Receptor Inhibition in Patients With ST-Elevation Myocardial Infarction Who Are Pre-treated With Crushed Ticagrelor
• Low Dose Ticagrelor Versus Low Dose Prasugrel in Patients With Prior Myocardial Infarction
• The Effect of Glucocorticoid Therapy on Left Ventricular Remodelling in Acute Myocardial Infarction (RECONSIDER)
• Safety and Efficacy of LMWH Versus Rivaroxaban in Chinese Patients Hospitalized With Acute Coronary Syndrome
• Adjunctive, Low-dose tPA in Primary PCI for STEMI
• Post- Myocardial Infarction Arterial Wall Improvement by Low-dose Fluvastatin and Valsartan
• Effects of Melatonin on Reperfusion Injury
• Efficacy of Intracoronary Infusion of Different Medicine in STEMI Patients With CSFP
• Evaluation of Decreased Usage of Betablockers After Myocardial Infarction in the SWEDEHEART Registry (REDUCE-SWEDEHEART)
• Paroxetine-mediated GRK2 Inhibition to Reduce Cardiac Remodeling After Acute Myocardial Infarction
• Efficacy of Intracoronary Infusion of Different Medicine in STEMI Patients Undergoing Primary PCI
• Effectiveness of Lower Maintenance Dose of Ticagrelor Early After Myocardial Infarction (ELECTRA) Pilot Study
• Platelet Inhibition With Cangrelor and Crushed Ticagrelor in STEMI
• Apixaban Versus Warfarin in Patients With Left Ventricular (LV) Thrombus
• Subclinical Cardiovascular Disease in Psoriatic Disease
• Influence of Vorapaxar on Thrombin Generation and Coagulability
• Cangrelor vs. Ticagrelor for Early Platelet Inhibition in STEMI
• Effect of Beta-blocker on Cardioprotective Effect of Remote Ischemic Conditioning
• CES1 Crossover Trial of Clopidogrel and Ticagrelor
• COlchicine for Left VEntricular Remodeling Treatment in Acute Myocardial Infarction
• Tailored Use of Tirofiban for Non-ST-elevation Acute Coronary Syndrome Patients
• Sonothrombolysis in Patients With STEMI
• Impact of EMpagliflozin on Cardiac Function and Biomarkers of Heart Failure in Patients With Acute MYocardial Infarction
• Rituximab in Patients With Acute ST-elevation Myocardial Infarction Study
• Colchicine and Spironolactone in Patients With MI / SYNERGY Stent Registry
• Transplantation Efficacy of Autologous Bone Marrow Mesenchymal Stem Cells With Intensive Atorvastatin in AMI Patients
• Cangrelor in ST-Elevation Myocardial Infarction to Decrease Infarct Size
• ASSessing the Effect of Anti-IL-6 Treatment in Myocardial Infarction: The ASSAIL-MI Trial
• Role of Oxytocin in Myocardial Infarction
• Mechanistic Effects of Colchicine in Patients With Myocardial Infarction
• Randomized Comparison of Cangrelor, Tirofiban and Prasugrel in Patients With STEMI Referred for Primary PCI.
• Effect of DLBS1033 After Primary PCI in Patients With STE-ACS
• A Double-blind Study to Investigate Efficacy, Safety and Tolerability of BAY 1142524 in Patients After Acute Myocardial Infarction With Left-ventricular Dysfunction
• Diffusion MRI in Heart Failure
• Cangrelor Following Ticagrelor Loading vs Ticagrelor Loading Alone in STEMI
• Alirocumab in Patients With Acute Myocardial Infarction
• Does Cyclosporine ImpRove Clinical oUtcome in ST Elevation Myocardial Infarction Patients at 3 Years of Follow-up. CIRCUS II Study
• Effect of Propofol on Cardioprotective Role of Remote Ischemic Preconditioning (RIPC)
• Antiplatelet Therapy Effect on Extracellular Vesicles in Acute Myocardial Infarction
• Study of Platelet Function After Administration of Aspirin Versus Lysine Acetylsalicylate in STEMI Patients
• Prospective ARNI vs ACE Inhibitor Trial to DetermIne Superiority in Reducing Heart Failure Events After MI
• Effects of Morphine on Loading-dose Ticagrelor in Patients With ST-segment Elevation Myocardial Infarction
• Efficacy of Furosemide Versus Vascular Filling in Patients With Acute Myocardial Infarction
• Sodium Thiosulfate to Preserve Cardiac Function in STEMI
• Bivalirudin in Acute Myocardial Infarction
• Optimal Coronary Flow After PCI for Myocardial Infarction - a Pilot Study
• Acute Coronary Syndrome Sri Lanka Audit Project
• The Effect of Tongguan Capsule for MicroRNA Profiles in Coronary Heart Disease Patients
• Ad-HGF Treatment for Myocardial Infarction
• The Efficacy and Safety of rhTNK-tPA in Comparison With Alteplase(Rt-PA) as Fibrinolytic Therapy of Acute STEMI
• PPI's and SSRI's Therapy for the Management of NCCP
• Comparison of Prasugrel and Ticagrelor in the Treatment of Acute Myocardial Infarction
• CardiOvascular Risk and idEntificAtion of Potential High-risk Population in Acute Myocardial Infarction II (COREA-AMI II)
• Effect of Testosterone Replacement on Exercise Capacity in Hypogonadal Men After a Recent Myocardial Infarction
• Ticagrelor Versus Clopidogrel in Myocardial Salvage in Patients With STEMI Undergoing Primary PCI
• STrategic Reperfusion in Elderly Patients Early After Myocardial Infarction
• Study to Evaluate the Efficacy, Safety and PK of Intravenous Single Injection LC28-0126 Immediately Before PCI in STEMI Patients
• Glycoprotein IIb/IIIa Inhibitors Versus Standard Therapy in Patients With Myocardial Infarction and No-reflow
• The Effect of IV Cangrelor and Oral Ticagrelor Study
• Trial to Assess Chelation Therapy 2
• Chewing Versus Traditional Oral Administration of Ticagrelor in STEMI Patients
• ShenFu Injection for Myocardial Protection in Patients With Acute ST Segment Elevation Myocardial Infarction
• What Are the Effects of Varenicline Compared With Nicotine Replacement Therapy on Long Term Smoking Cessation and Clinically Important Outcomes?
• Danlou Tablets to Prevent Left Ventricular Remodeling
• Sevoflurane and Percutaneous Coronary Intervention by Stent
• EXCELLENT (EXpanded CELL ENdocardiac Transplantation)
• A Randomized, Pharmacodynamic Comparison of Low Dose Ticagrelor to Clopidogrel in Patients With Prior Myocardial Infarction
• Hydroxychloroquine for the Prevention of Cardiovascular Events in Myocardial Infarction Patients - a Safety Pilot Trial
• Safety of Topical Tranexamic Acid in Total Joint Arthroplasty in High Risk Patients
• Aspirin Versus Aspirin+Clopidogrel as Antithrombotic Treatment Following TAVI
• What is the Optimal antiplatElet and Anticoagulant Therapy in Patients With Oral Anticoagulation Undergoing revasculariSaTion 2.
• Influence of Vorapaxar on Thrombin Generation and Coagulability
• Impact of Morphine Treatment on Platelet Inhibition in Acute Myocardial Infarction
• Assessment of Loading With the P2Y12 Inhibitor Ticagrelor or Clopidogrel to Halt Ischemic Events in Patients Undergoing Elective Coronary Stenting
• Comparison of Ticagrelor Pharmacokinetics and Pharmacodynamics in STEMI and NSTEMI Patients
• Harmonizing Optimal Strategy for Treatment of Coronary Artery Stenosis - Coronary Intervention With Next Generation Drug-Eluting Stent Platforms and Abbreviated Dual Antiplatelet Therapy (HOST-IDEA) Trial
• Secondary Prevention of Cardiovascular Disease in the Elderly Trial
• Intracoronary Cocktail Injection Combined With Thrombus Aspiration in STEMI Patients Treated With Primary Angioplasty
• Reappraisal of GIK in Acute STEMI by Pre-hospital Administration
• Assessment of the Effects of Atorvastatin Therapy on Myocardial Deformation Characteristics, in Patients With STEMI
• GLP-1 on Non-ST-Segment Elevation Myocardial Infarction
• Bivalirudin Infusion for Ventricular Infarction Limitation
• Changes in Myocardial Biomechanics and Early Short-term Doxycycline Therapy in Patients With Primary Anterior STEMI
• NP202 for Treatment of Post -STEMI Left Ventricular Systolic Dysfunction
• Colchicine Cardiovascular Outcomes Trial (COLCOT)
• Vorapaxar as an Add-On Antiplatelet Therapy in Patients With and Without Diabetes Mellitus
• Effect of Vitamin D on Ventricular Remodeling in Patients With Acute Myocardial Infarction (VITDAMI)
• Vorapaxar in Patients With Prior Myocardial Infarction Treated With Prasugrel and Ticagrelor
• Platelet Inhibition After Pre-hospital Ticagrelor Using Fentanyl Compared to Morphine in Patients With ST-segment Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention
• Sodium Tanshinone IIA Sulfonate in Left Ventricular Remodeling Secondary to Acute Myocardial Infarction
• Thyroid Hormone Replacement for Hypothyroidism and Acute Myocardial Infarction(ThyroHeart-AMI)
• Effects of Glucagon Like Peptide-1 on No-reflow
• The Transendocardial Autologous Cells (hMSC) or (hMSC) and (hCSC) in Ischemic Heart Failure Trial.
• RIGENERA 2.0 Trial
• Anfibatide Treatment in STEMI Patients
• Left Atrial Appendage Closure Compared to Standard Antiplatelet Therapy in Patients With AF Who Underwent PCI
• Pain Management After Cardiac Surgery - Opioids or NSAID
• Acute Myocardial Necrosis and Depression: Antiplatelet Effect of Reuptake Inhibition of Serotonin
• Effects of Nicorandil on Cardiac Infarct Size in Patients With ST-segment Elevation Acute Myocardial Infarction
• Efficacy and Safety of BiomatrixTM Stent and 5mg-Maintenance Dose of Prasugrel in Patients With Acute Coronary Syndrome
• Effect of Nicorandil for the Patients of Acute ST Segment Elevation Myocardial Infarction
• A Multicenter Trial to Assess the MIcrovascular Integrity and Left Ventricular Function Recovery After Clopidogrel or TicagrelOr Administration, in Patients With STEMI Treated With Thrombolysis - The 'MIRTOS' Study
• Role of Immune Responses After Acute Myocardial Infarction
• Reducing Micro Vascular Dysfunction in Acute Myocardial Infarction by Ticagrelor
• Short-Term Application of Tocilizumab Following Myocardial Infarction
• Brilinta Taiwan Post Approval Safety Study
• COMBinAtion Therapy in Myocardial Infarction: The COMBAT-MI Trial
• Sub Lingual Versus Traditional Oral Administration of Ticagrelor in Acute Coronary Syndrome/Non ST-elevation Myocardial Infarction - A Platelet Reactivity Study
• DPP-4 Inhibitors and Acute Myocardial Infarction:Effects on Platelet Function
• P3AMI Antiplatelet Trial
• Interest of COLchicine in the Treatment of Patients With Acute Myocardial INfarction and With Inflammatory Response
• Ticagrelor or Prasugrel Versus Clopidogrel in Elderly Patients With an Acute Coronary Syndrome and a High Bleeding Risk: Optimization of Antiplatelet Treatment in High-risk Elderly
• Bivalirudin vs Heparin in NSTEMI and STEMI in Patients on Modern Antiplatelet Therapy in SWEDEHEART
• Medical ANtiarrhythmic Treatment or Radiofrequency Ablation in Ischemic Ventricular Tachyarrhythmias
• Single Bolus Recombinant Nonimmunogenic Staphylokinase (FORtelyzin) Versus Single Bolus Tenecteplase (Metalyse) in STEMI
• Ticagrelor in Patients With ST Elevation Myocardial Infarction Treated With Pharmacological Thrombolysis
• Ticagrelor Pharmacokinetics in NSTEMI
• Effects of HTEA ON Heart Failure Secondary to Idiopathic Dilated Cardiomyopathy or Post-myocardial Infarction
• Bezafibrate for Hyperfibrinogenemia in Acute Myocardial Infarction
• Determination of the Role of Oxygen in Suspected Acute Myocardial Infarction by Biomarkers
• Effects of Oxygen Treatment on Mechanisms Involved in Ischemia-reperfusion Injury: A Pilot Study in Healthy Volunteers
• Post-MI PET Scan Imaging of Inflammation
• Research on Infarction With Open Arteries Using OCT and CMR
• A Trial of Low-dose Adjunctive alTeplase During prIMary PCI
• Impairment of Gastric Emptying During Acute Phase of Myocardial Infarction. Impact on Oral Antiplatelet Treatment Efficacy. The GASTRIM Study.
• Antiplatelet Therapy for Patients Undergoing Transcatheter Aortic Valve Implantation
• A Study of Pre-hospital Treatment of Acute Myocardial Infarction Based on Diagnosis by Interpretation of Remotely Acquired ECG and Thrombolysis With Accelerated Alteplase ( Actilyse®)
• Ticagrelor and Clopidogrel on Reperfusion in Patients With AMI
• Ticagrelor Versus Clopidogrel in Left Ventricular Remodeling After ST-segment Elevation Myocardial Infarction
• Antiplatelet Therapy After Cardiac Arrest
• Influence of Morphine on Pharmacokinetics and Pharmacodynamics of Ticagrelor in Patients With Acute Myocardial Infarction
• Pharmacological Effects of Crushing Prasugrel in STEMI Patients
• Post Marketing Surveillance to Monitor the Safety and Efficacy of Metalyse® in Korean Patients With Acute Myocardial Infarction
• Surveillance of Patients With Suspected Acute Myocardial Infarction That Receive Early Inhospital Thrombolysis With Metalyse
• Observational Study of METALYSE® in Patients With Acute Myocardial Infarction In Russian Federation
• A Study to Investigate the Procoagulant Effect of Tenecteplase (TNK-tPA), Alteplase (Rt-PA) and Streptokinase (SK) Administered to Patients With Acute Myocardial Infarction (AMI)
• A Trial on Efficacy and Safety of Full Dose Tenecteplase Combined With Unfractionated Heparin (UFH) or Enoxaparin in Acute Myocardial Infarction (AMI) in the Prehospital Setting
• Full Dose Tenecteplase (TNK-tPA) Together With Heparin Sodium, Full Dose Tenecteplase With Enoxaparin, Half Dose Tenecteplase Together With Abciximab and Heparin Sodium in Patients With Acute Myocardial Infarction (AMI)
• Microvascular Reperfusion Utilizing Sonothrombolysis in Acute Myocardial Infarction (MRUSMI TRIAL)
• the Effect of Danhong Injection on Microcirculation in the Treatment of Patients With STEMI After the PTCA Surgery.
• DLBS1033 for Acute NSTEMI Without Early Coronary Revascularization
• Effects of Intracoronary Prourokinase on the Coronary Flow During Primary Percutaneous Coronary Intervention for Acute Myocardial Infarction
• GLP-1 Loading During Elective Percutaneous Coronary Intervention
• Comparison of Ticagrelor And Clopidogrel on Inflammatory Biomarkers And Vascular Endothelial Function
• A Randomized Trial of Intracoronary Reopro to Improve Coronary Microvascular Function
• Concomitant Milrinone and Esmolol Treatment in Patients With Acute Myocardial Infarction
• COlchicine Improve EnDothElial Function in Non ST Elevation Myocardial Infarction Patients
• Prasugrel and Ticagrelor in ST-segment Elevation Myocardial Infarction
• CD-NP (Cenderitide) Therapy for the Preservation of Left Ventricular Function
• Efficacy of Vitamin E in Preventing Contrast-Induced Acute Kidney Injury Following Coronary Angiography
• Phase 2 Study to Evaluate the Efficacy, Safety and PK of Intravenous Single Injection LC28-0126 Immediately Before PCI in STEMI Patients
• Aggressive hydraTion in Patients With ST -Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention to prevenT Contrast-Induced Nephropathy
• Comparing Ticagrelor and Clopidogrel Pharmacodynamics After Thrombolysis
• OraL Crushed and dIspersed Ticagrelor 180mg Compared to Whole Tablets of eQUal Dose in STEMI Patients unDergoing Primary PCI: a Pharmacokinetic/Pharmacodynamic Study (the LIQUID Study)
• Impact of Ticagrelor on the Endothelial Healing Following Drug-eluting Stent Implantation in the Patients With Acute Coronary Syndrome
• Assessment of Coronary Flow Reserve by Doppler Flow WIre in Patients With Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention: Differences Between the Loading Dose of Prasugrel and Ticagrelor .
• Assessment of Coronary Flow Reserve by Doppler Flow Wire in Patients With Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention Differences Between the Loading Dose of Ticagrelor and Clopidogrel
• Comparison of Clopidogrel and Ticagrelor on Microvascular Dysfunction in ST-Segment Elevation Myocardial Infarction
• TicAgrelor Versus CLOpidogrel in Stabilized Patients With Acute Myocardial Infarction: TALOS-AMI
• Pharmacokinetics and Pharmacodynamics of Ticagrelor in Patients With Stable Angina, NSTEMI and STEMI Undergoing PCI
• Efficacy Study of Glucagonlike Peptide-1 to Treat Reperfusion Injury
• Sequential Therapy of Atorvastatin Improve Outcomes of ST-elevated Acute Myocardial Infarction
• Phase 2 Clinical Proof-of-Concept Study of the Cardioprotective Properties of Danegaptide in ST Segment Elevation Myocardial Infarction
• STem cElls Mobilization in Acute Myocardial Infarction Outcome Trial
• Ticagrelor vs High Dose Clopidogrel in Patients With ST Elevation Myocardial Infarction Post Fibrinolysis
• Interleukin-1 (IL-1) Blockade in Acute Myocardial Infarction (VCU-ART3)
• Exenatide for Myocardial Protection During Reperfusion Study
• Alpha-1 Anti-Trypsin (AAT) Treatment in Acute Myocardial Infarction
• Colchicine in ST-elevation Myocardial Infarction
• Effects of Intensive Statin Treatment on Left Ventricular Function
• EARLY Routine Catheterization After Alteplase Fibrinolysis vs. PPCI in ST-Segment-Elevation MYOcardial Infarction
• Ticagrelor for PCI Post Thrombolysis
• Intensive Statin Therapy in Patients With AMI
• CXCR4 Antagonism for Cell Mobilisation and Healing in Acute Myocardial Infarction (CATCH-AMI)
• Cyclosporine in Acute Myocardial Infarction Complicated by Cardiogenic Shock
• Early Mineralocorticoid Receptor Antagonist Treatment to Reduce Myocardial Infarct Size
• Effects of N-acetyl Cysteine During Primary Percutaneous Coronary Intervention
• A Study to Assess the Effectiveness and Safety of Rivaroxaban in Reducing the Risk of Death, Myocardial Infarction or Stroke in Participants With Heart Failure and Coronary Artery Disease Following an Episode of Decompensated Heart Failure
• Clinical Effects of Eptifibatide Administration in High Risk Patients Presenting With Non-ST Segment Elevation Acute Coronary Syndrome (NSTE-ACS) Requiring Urgent Coronary Artery Bypass Graft Surgery in Short- and Long-Term Follow-up
• Omega-3 Fatty Acids in Elderly Patients With Acute Myocardial Infarction
• High (100mg) Versus Standard (60mg) Loading Dose of Prasugrel in Patients With ST-elevation Myocardial Infarction (STEMI), Undergoing Primary Percutaneous Coronary Intervention (PCI)
• Bedside Testing of CYP2C19 Gene for Treatment of Patients With PCI With Antiplatelet Therapy
• Rapid Activity of Platelet Inhibitor Drugs Study 2
• An Efficacy and Outcome Study of Supplemental Oxygen Treatment in Patients With Suspected Myocardial Infarction
• Atorvastatin for Reduction of Myocardial Damage During Angiography and Its Mechanism Associated With IMR
• Anti-inflammatory Effects of Intracoronary and Intravenous Abciximab Administration During Primary Percutaneous Coronary Intervention
• REperfusion Facilitated by LOcal Adjunctive Therapy in ST-elevation Myocardial Infarction
• Early Hydration in Acute Myocardial Infarction
• The Effects of mETHotrexate Therapy on ST Segment Elevation MYocardial InfarctionS (TETHYS Trial)
• Effect of N-acetylcystein in Myocardial Infarction
• On-treatment PLAtelet Reactivity-guided Therapy Modification FOR ST-segment Elevation Myocardial Infarction
• Ticagrelor and Intracoronary Morphine in Patients Undergoing Primary Percutaneous Coronary Intervention
• Physical and Chemical Study of Atherosclerosis Mechanisms
• BivaliRudin in Acute Myocardial Infarction vs Glycoprotein IIb/IIIa and Heparin :a Randomised Controlled Trial.
• DEDICA (Dose of HEparin During Coronary Angioplasty) Trial
• CYCLosporinE A in Reperfused Acute Myocardial Infarction
• Pharmacoinvasive Therapy With Prourokinase
• WEUKBRE5554: IMI PROTECT(Work Package 2): Beta2 Agonists and Acute Myocardial Infarction
• Effect of the Repeated Loading Dose of Clopidogrel and High Dose of Clopidogrel Continuous Therapy on the Platelet Aggregation Inhibition in Patients With Myocardial Infarction Undergoing Interventional Treatment.
• Aminophylline and Contrast Induced Nephropathy in Acute Myocardial Infarction
• Aspirin Resistance and Stroke Risk: Platelet Function Analysis in Patients With Ischemic Events
• Anfibatide Phase Ib-IIa Clinical Trial
• Safety and Effectiveness of Intra-coronary Nitrite in Acute Myocardial Infarction
• Myocardial Protection of Exenatide in AMI
• Standard (180mg) Versus Double (360mg) Loading Dose of Ticagrelor in Patients With ST-elevation Myocardial Infarction (STEMI), Undergoing Primary Percutaneous Coronary Intervention (PCI)
• Evaluation of Myocardial Effects of MTP-131 for Reducing Reperfusion Injury in Patients With Acute Coronary Events
• Clopidogrel Reloading in Patients With NSTEACS Undergoing Percutaneous Coronary Intervention on Chronic Clopidogrel Therapy
• Aspirin Versus Aspirin + ClopidogRel Following Transcatheter Aortic Valve Implantation: the ARTE Trial
• LV Thrombus After Acute AMI: A Randomized Controlled Trial
• Bivalirudin Plus Stenting in Long Lesion to Avoid Periprocedural Myocardial Necrosis Trial
• Lowering the Risk of Operative Complications Using Atorvastatin Loading Dose
• 68Ga-BNOTA-PRGD2 PET/CT in Evaluation of Myocardial Infarction
• Study to Evaluate the Safety and Activity of BB3 to Treat Heart Attack
• Intracoronary Darbepoetin-alpha to Reduce The Infarct Size and Post-Infarct Remodeling
• PraSugrel vs TicagrElor in ST-Elevation Myocardial Infarction paTients With Diabetes Mellitus
• Controlled Level EVERolimus in Acute Coronary Syndromes
• Metoprolol in Acute Myocardial Infarction. A PK/PD Study
• Shortened Aggrastat® Versus Integrilin in Percutaneous Coronary Intervention
• How Effective Are Antithrombotic Therapies in Primary Percutaneous Coronary Intervention
• Rapid Activity of Platelet Inhibitor Drugs Study
• Cyclosporine and Prognosis in Acute Myocardial Infarction (MI) Patients
• Effects of N-acetylcysteine on Low T3 Syndrome
• Half-Dose Radiopharmaceutical in Wide Beam Reconstruction
• Randomized Trial of Standard vs ClearWay-infused Abciximab and Thrombectomy for Myocardial Infarction
• Effect of the Interleukin-6 Receptor Antagonist Tocilizumab in Non-ST Elevation Myocardial Infarction
• Carvedilol Vascular Efficacy Trial
• Ticagrelor in Comparison to Prasugrel for Early Inhibition of Platelet Reactivity in Patients With ST-elevation Myocardial Infarction (STEMI), Undergoing Primary Percutaneous Coronary Intervention (PCI)
• Allogeneic Heart Stem Cells to Achieve Myocardial Regeneration
• Pharmacogenetic Approach to Anti-platelet Therapy for the Treatment of ST-segment Elevation Myocardial Infarction (STEMI)
• Evaluation of the Safety and Efficacy of Using Insulin-like Growth Factor-1 in Patients With a Heart Attack
• Supplemental Oxygen in Catheterized Coronary Emergency Reperfusion
• Effects of High-dose n-3 Fatty Acids on Clinical Outcome and Serum Lipids - Omacor Following Acute Myocardial Infarction
• Efficacy of Combination of IntraCoronary Bolus Abciximab and Aspiration Thrombectomy in STEMI
• Effects of Nitric Oxide for Inhalation in Myocardial Infarction Size
• Safety and Efficacy of Intracoronary Adult Human Mesenchymal Stem Cells After Acute Myocardial Infarction
• Nitrites in Acute Myocardial Infarction
• Ezetimibe In Addition To Atorvastatin Therapy On The Plaque Composition In Patients With Acute Myocardial Infarction.
• Microcirculation In Acute Coronary Syndromes
• REsistance to Aspirin and Clopidogrel in acuTe Myocardial Infarction
• Safety and Efficacy Study of TRO40303 for Reduction of Reperfusion Injury in Patients Undergoing Percutaneous Coronary Intervention for Acute Myocardial Infarction
• Etanercept Treating Patient With Acute ST Segment Elevated Myocardial Infarction
• Intensive Statin Therapy in PCI Patient With Acute Coronary Syndrome
• Drug Drug Interactions of Aspirin and P2Y12-inhibitors
• Study Comparing the Efficacy and Tolerability of Epinephrine and Norepinephrine in Cardiogenic Shock
• Patients With High-risk Acute Coronary Syndrome Without ST-segment Elevation
• A 30 Day Study to Evaluate Efficacy and Safety of Pre-hospital vs. In-hospital Initiation of Ticagrelor Therapy in STEMI Patients Planned for Percutaneous Coronary Intervention (PCI)
• The Impact of Dose of Angiotensin-receptor Blocker Valsartan and Genetic Polymorphism on the Post-MI Ventricular Remodeling
• Prasugrel in Comparison to Clopidogrel for Inhibition of Platelet Reactivity in Patients With ST-elevation Myocardial Infarction (STEMI)
• Facilitation Through Aggrastat By drOpping or Shortening Infusion Line in Patients With ST-segment Elevation Myocardial Infarction Compared to or on Top of PRasugrel Loading dOse
• The Clinical Effect of Intensive Statin Therapy in STEMI Patients Before Emergency PCI
• Cardiovascular Risk Reduction Study (Reduction in Recurrent Major CV Disease Events)
• Early Thienopyridine Treatment to Improve Primary PCI in Patients With Acute MI
• A Study of RO4905417 in Patients With Non ST-Elevation Myocardial Infarction (Non-STEMI) Undergoing Percutaneous Coronary Intervention
• Fixed Dose Combination Drug (Polypill)for Secondary Cardiovascular Prevention.
• Effect of METOprolol in CARDioproteCtioN During an Acute Myocardial InfarCtion. The METOCARD-CNIC Trial.
• A Study of the Safety and Efficacy of Injectable Thymosin Beta 4 for Treating Acute Myocardial Infarction
• A Trial Using Double-Bolus THR-100 Versus Streptokinase
• Intensive Statin Treatment in Chinese Coronary Artery Disease Patients Undergoing PCI
• Safety and Tolerability of RNS60 Given by IV to Healthy Subjects
• Efficacy and Safety of Adjunctive Cilostazol in Acute Myocardial Infarction Patients
• Effect of Additional Treatment With EXenatide in Patients With an Acute Myocardial Infarction (the EXAMI Trial)
• Influence of Intensive Lipid Lowering Treatment Compared to Moderate Lipid Lowering Treatment
• Aggrastat Truncated Length Against Standard Therapies in Percutaneous Coronary Intervention
• Escalating Clopidogrel by Involving a Genetic Strategy - Thrombolysis In Myocardial Infarction 56
• ROsuvastatin Pretreatment to Reduce MyocArdial Periprocedural Necrosis:Comparison With Atorvastatin Reloading
• Prevention of Cardiovascular Events (eg, Death From Heart or Vascular Disease, Heart Attack, or Stroke) in Patients With Prior Heart Attack Using Ticagrelor Compared to Placebo on a Background of Aspirin
• Sodium Bicarbonate and N-Acetylcysteine for Nephroprotection in Acute Myocardial Infarction
• Metformin to Reduce Heart Failure After Myocardial Infarction
• Effect of Statin Treatment on Insulin Sensitivity During Myocardial Infarction
• Effect of Intensive Lipid Lowering Treatment Compared to Moderate Lipid Lowering Treatment on Carotid Intima-media Thickness (CIMT)
• Morphine In Acute Myocardial Infarction
• Ilomedin Treatment for Patients Having Undergone Primary Percutaneous Coronary Intervention (PCI)
• Impact Of Eplerenone On Cardiovascular Outcomes In Patients Post Myocardial Infarction
• Anakinra to Prevent Adverse Post-infarction Remodeling (2)
• Renin-angiotensin-aldosterone System Polymorphisms in Resistant Hypertension and Adverse Cardiovascular Events
• The Effect of Melatonin on Ischemia-reperfusion Injury Following Acute Myocardial Infarction
• Prevention of Contrast-induced Nephropathy in Patients With Acute Myocardial Infarction
• Bivalirudin/Prasugrel Versus Abciximab/Clopidogrel in Patients Presenting With STEMI
• Carvedilol Post-intervention Long-term Administration in Large-scale Trial
• The Effects of Lovaza® in Acute Myocardial Infarction
• Acetaminophen to Prevent Ischemic Oxidative Reperfusion Injury During Percutaneous Coronary Intervention for Acute Myocardial Infarction
• Tirofiban Intracoronary Bolus-only Versus Intravenous Bolus Plus Infusion in STEMI Patients
• Hemoglobin Kinetics in Response to Mircera® in Patients With Acute Myocardial Infarction
• Intracoronary Bolus Only Compared With Intravenous Bolus and 12-hours Infusion of Abciximab in Non-ST Elevation Myocardial Infarction.
• Effect of Otamixaban Versus Unfractionated Heparin + Eptifibatide in Patients With Unstable Angina/Non ST Elevation Myocardial Infarction Undergoing Early Invasive Strategy
• Using AtorVASTatin to Prevent VAscular Inflammatory OccLUSion in the Critically Ill
• Influence of Esomeprazole on Antiplatelet Action of Clopidogrel Associated With Aspirin
• Aldosterone Blockade Early After Acute Myocardial Infarction
• Influence of Intensive Lipid Lowering Treatment Compared to Moderate Lipid Lowering Treatment on Plaque Composition in Patients With ST-Segment Elevation Myocardial Infarction (MI)
• HIV Treatment and CVD Events
• To Investigate the Role of Upstream High Dose Statin in STEMI
• Intracoronary Injection of Epo After Myocardial Infarct "Intra-CO-EpoMI"
• Safety, Pharmacokinetic and -Dynamic Study of PR-15, an Inhibitor of Platelet Adhesion
• Comparative Study of ALX-0081 Versus GPIIb/IIIa Inhibitor in High Risk Percutaneous Coronary Intervention (PCI) Patients
• A Comparison of Prasugrel at PCI or Time of Diagnosis of Non-ST Elevation Myocardial Infarction
• IK-1001 (Sodium Sulfide (Na2S) for Injection) in Subjects With Acute ST-Segment Elevation Myocardial Infarction
• Rosuvastatin in Preventing Myonecrosis in Elective Percutaneous Coronary Interventions (PCIs)
• Comparison of Drug Eluting and Bare Metal Stents With or Without Abciximab in ST Elevation Myocardial Infarction
• Strengthening Transplantation Effects of Bone Marrow Mononuclear Cells With Atorvastatin in Myocardial Infarction
• The INFUSE - Anterior Myocardial Infarction (AMI) Study
• Efficacy Study of Combined Prasugrel and Bivalirudin Versus Clopidogrel and Heparin in Myocardial Infarction
• Sevoflurane In Acute Myocardial Infarction
• Cardiovascular Magnetic Resonance for the Occluded Infarct-Related Artery Treatment
• Statin Drugs to Prevent Complications During Surgery
• Mangafodipir as an Adjunct to Percutaneous Coronary Intervention
• Effectiveness of Intracoronary Injection of Eptifibatide in Primary Coronary Intervention in STEMI Patients
• Comparison of Intracoronary Versus Intravenous Abciximab in ST-segment Elevation Myocardial Infarction (CICERO)
• Sodium Nitrite in Acute Myocardial Infarction
• Adjunctive Cilostazol Versus High Maintenance-dose ClopidogrEL in Acute Myocardial Infarction (AMI) Patients According to CYP2C19 Polymorphism
• Tailoring Of Platelet Inhibition to Avoid Stent Thrombosis
• A Study to Evaluate the Safety of 12 Weeks of Dosing With GW856553 and Its Effects on Inflammatory Markers, Infarct Size, and Cardiac Function in Subjects With Myocardial Infarction Without ST-segment Elevation
• Simvastatin Effect on Inflammation and Endothelial Function After Myocardial Infarction
• Additive Effect of Ezetimibe Upon Simvastatin During Myocardial Infarction
• Intracoronary Abciximab With Clearway Catheter
• Comparative Evaluation of Various Combinable Magnetic Resonance (CMR) Pulse-sequences for Macrophage Imaging Using Ferucarbotran
• Ex Vivo Cultured Bone Marrow Derived Allogenic MSCs in AMI
• Safety and Efficacy of Three Different Loading Doses of Clopidogrel, in Patients With Acute Myocardial Infarction
• The STREAM Percutaneous Coronary Intervention Anticoagulant Sub-study
• The Effect of Erythropoietin at the Time of Reperfusion in Acute Myocardial Infarction
• Safety and Efficacy of SeeMore (TM) in Heart Patients
• Plaque Inflammation and Dysfunctional HDL in AIM-HIGH
• Prochymal® (Human Adult Stem Cells) Intravenous Infusion Following Acute Myocardial Infarction (AMI)
• The Effect Of Acadesine On Reducing Cardiovascular and Cerebrovascular Adverse Events In Coronary Artery Bypass Graft (CABG) Surgery (Study P05633 AM1)(TERMINATED)
• Effects of Telmisartan on Ischemic Cardiovascular Events in High-risk Hypertensive Patients
• Tight Glycemic Control Increases Cardiac Stem Cells During Acute Myocardial Infarction
• PET/CT Study in the Diagnosis of Coronary Plaque
• Nicorandil Study to Reduce Cardiac Death After Percutaneous Coronary Intervention (PCI) in Hemodialysis Patients
• Efficacy of Early Administration of Clotinab in Acute Myocardial Infarction
• Pharmacological Postconditioning to Reduce Infarct Size Following Primary PCI
• A Clinical Evaluation of Everolimus Eluting Coronary Stents in the Treatment of Patients With ST-segment Elevation Myocardial Infarction: EXAMINATION Study
• Comparison Between Iso-Osmolar and Ipo-Osmolar Contrast Agents in Patients With Acute Myocardial Infarction (AMI) Undergoing Primary Percutaneous Coronary Intervention (PCI)
• Safety Evaluation of Clopidogrel Sulfate in Patients With Stable Angina/Old Myocardial Infarction to Whom Percutaneous Coronary Intervention is Being Planned
• Prothrombin Times Outside the Therapeutic Range in Otherwise Stable Patients
• Eptifibatide and ST Segment Resolution Following Primary PCI
• An Efficacy and Safety Study for Rivaroxaban in Patients With Acute Coronary Syndrome
• Efficacy of High Dose atorvaSTATIN Loading Before Primary Percutaneous Coronary Intervention in ST Elevation Myocardial Infarction (STATIN STEMI)
• Comparison Between Thrombolysis and Primary Percutaneous Coronary Intervention (PCI) to Treat ST-Segment Elevation Myocardial Infarction
• To Relieve Pain and Anxiety - an Intervention Study in Ambulance Services
• Fondaparinux Trial With Unfractionated Heparin (UFH) During Revascularization in Acute Coronary Syndromes (ACS)
• Anakinra to Prevent Post-infarction Remodeling
• Safety and Efficacy Study of KAI-9803 to Treat Subjects With ST Elevation Myocardial Infarction [Heart Attack]
• Study of Optimal Clopidogrel Duration in Patients Receiving Drug Eluting Stents (SCORE Trial)
• Myocardial Protection With Adenosine During Primary Percutaneous Coronary Intervention in Pts With STEMI
• The Use of Statins for Myocardial Death Prevention
• Randomized, Controlled Study on Short-term Psychotherapy After Acute Myocardial Infarction
• Alcohol, Inflammation and Atherosclerosis
• The Effect of Granulocyte Colony Stimulating Factor (G-CSF) on Myocardial Function After Acute Anterior Myocardial Infarction, a Prospective Double Blind Randomized Placebo Controlled Study
• A Phase 1 Safety Study of the Intravenous Administration of Thymosin Beta in Healthy Volunteers
• Intravenous Exenatide in Coronary Intensive Care Unit (ICU) Patients
• Effect of High Dose Fish Oil Supplementation After Recent Heart Attack Using Magnetic Resonance Imaging
• A Safety/Efficacy Study of Intracoronary Integrilin to Improve Balloon Angioplasty Outcomes for the Treatment of Heart Attacks
• Clopidogrel as Adjunctive Reperfusion Therapy - Thrombolysis in Myocardial Infarction
• Effects of Different Vasodilators on Coronary No-reflow During primAry percuTaneous Coronary intErvention in Patients With Acute Myocardial Infarction
• Abciximab i.v. Versus i.c. in ST-elevation Myocardial Infarction
• Telmisartan Versus Ramipril After Acute Coronary Syndrome
• Thromboelastography As An Assessment Tool for Possible Clopidogrel and Aspirin Resistance
• N-3 Fatty Acids for the Prevention of Atrial Fibrillation in Patients With Acute Heart Failure
• Infusion of a Single Dose of Erythropoietin to Prevent Injury in an Ischemia Reperfusion Forearm Model
• Comparison of ATI-5923, a Novel Vitamin K Antagonist, With Warfarin in Patients Requiring Chronic Anticoagulation
• Zyban as an Effective Smoking Cessation Aid for Patients Following an Acute Coronary Syndrome: The ZESCA Trial
• Pravastatin for Acute Myocardial Infarction With Minimally to Mildly Increased Levels of Serum Cholesterol Study
• Trial to Assess the Safety and Effects of Vorapaxar in Japanese Subjects With Acute Coronary Syndrome (P04772; MK-5348-016)
• Prevention of Gastrointestinal Bleeding in Patients With Severe Ischemic Heart Disease
• Effect of Lantus and Apidra in Patients With Acute ST Elevation Myocardial Infarction
• Warfarin After Anterior ST-Elevation Myocardial Infarction
• Sitagliptin Plus Granulocyte-colony Stimulating Factor in Acute Myocardial Infarction
• EPOMI Study: ErythroPOietin in Myocardial Infarction
• Mechanisms of Action of Acetaminophen
• REsearching Coronary REduction by Appropriately Targeting Euglycemia (RECREATE Pilot Study)
• The Melatonin Adjunct in the Acute myocaRdial Infarction Treated With Angioplasty
• Effects of Hydration to Prevent Contrast Induced Nephropathy in PCI for ST-elevation Myocardial Infarction.
• INSTANT: INtegrilin Plus STenting to Avoid Myocardial Necrosis Trial
• Myocardial Infarction With ST-Elevation
• Effect of Adjunctive Intracoronary Streptokinase on Late Term Left Ventricular Infarct Size and Volumes in Patients With Acute Myocardial Infarction
• Beta-cell Function in Glucose Abnormalities and Acute Myocardial Infarction
• STREAM-Strategic Reperfusion (With Tenecteplase and Antithrombotic Treatment) Early After Myocardial Infarction
• Trial to Assess the Ocular Safety of Vorapaxar (SCH 530348) in Participants With Atherosclerosis (Study P05183)
• The Effects of Facilitated Percutaeous Coronary Intervention in Acute Myocardial Infarction
• A Safety/Efficacy Study of Intra-coronary Tenecteplase During Balloon Angioplasty to Treat Heart Attacks
• Effects of Pyruvate in Patients With Cardiogenic Shock and Intra-aortic Balloon Counterpulsation
• THE REOPEN-AMI STUDY - Intracoronary Nitroprusside Versus Adenosine in Acute Myocardial Infarction
• Role of Endothelin in Microvascular Dysfunction Following PCI for NSTEMI
• Nesiritide Therapy to Preserve Function of the Left Ventricle After Myocardial Infarction
• Nitric Oxide in Myocardial Infarction Size
• Clopidogrel and the Optimization of Gastrointestinal Events (COGENT-1)
• Safety and Efficacy Study of Adjunctive Antiplatelet Therapy Prior to Primary PCI in Patients With STEMI
• GPIIbIIIa Inhibitors in the RESCUe and RESURCOR Networks at the Acute Myocardial Infarction
• Effects of Atorvastatin 10 mg Versus 40 mg in Eight Months Follow-up Coronary Flow Reserve and Bone Marrow Stem Cell Mobilization in Patients With Acute Myocardial Infarction
• Diagnostics for the Reperfusion Injury Following MI
• Trial to Assess the Effects of Vorapaxar (SCH 530348; MK-5348) in Preventing Heart Attack and Stroke in Particpants With Acute Coronary Syndrome (TRA•CER) (Study P04736)
• Trial to Assess the Effects of Vorapaxar (SCH 530348; MK-5348) in Preventing Heart Attack and Stroke in Patients With Atherosclerosis (TRA 2°P - TIMI 50) (P04737)
• Endothelin Receptor Blockade in Acute ST-elevation Myocardial Infarction
• MAGIC Cell-5-Combicytokine Trial
• Aspirin in Patients With Myocardial Infarction and Thrombocytopenia
• Glutamate for Metabolic Intervention in Coronary Surgery
• Does Heme Oxygenase-1 Induction Ameliorate Cardiac Injury After Myocardial Infarction?
• Tetracycline (Doxycycline) and Post Myocardial Infarction Remodeling
• Myocardial Salvage and Contrast Dye Induced Nephropathy Reduction by N-Acetylcystein
• Clinical Study to Examine the Effects of Erythropoietin on Left Ventricular Function After Acute Myocardial Infarction
• Randomized Clinical Trial of Adipose-Derived Stem Cells in the Treatment of Pts With ST-elevation Myocardial Infarction
• A Randomized Trial of Early Discharge After Trans-radial Stenting of Coronary Arteries in Acute MI and Rescue-PCI
• A Randomized Trial of Early Discharge After Trans-radial Stenting of Coronary Arteries in Acute MI
• Dalteparin Versus Unfractionated Heparin In Patients With Acute Coronary Syndrome
• Harmonizing Outcomes With Revascularization and Stents in Acute Myocardial Infarction
• Effect of Intravenous Immunglobulin (IVIG) After Myocardial Infarction
• Efficacy Of Eptifibatide Compared To Abciximab In Primary Percutaneous Coronary Intervention (PCI) For Acute ST Elevation Myocardial Infarction (STEMI)
• Anti-Restenosis After AMI by Erythropoietin
• The Effect of GLP-1 on Glucose Uptake in the Brain and Heart in Healthy Men During Hypoglycemia
• Safety and Efficacy of Aliskiren in Post Myocardial Infarction Patients (ASPIRE)
• Ciclosporin A and Acute Myocardial Infarction
• Stem Cell Mobilization by G-CSF Post Myocardial Infarction to Promote Myocyte Repair
• Efficacy Study of Erythropoietin After Revascularization in Myocardial Infarction (REVIVAL-3)
• FATA: Randomized Study on Facilitated Angioplasty With Tirofiban or Abciximab
• REVEAL: Reduction of Infarct Expansion and Ventricular Remodeling With Erythropoietin After Large Myocardial Infarction
• A Postmarketing Study of the Risk of Venous Thromboembolism (Blood Clots), Myocardial Infarction (Heart Attacks), and Stroke Among Women Using ORTHO EVRA (Norelgestromin and Ethinyl Estradiol Contraceptive Patch) Compared With Women Who Take Oral Co
• Randomized Comparison of Abciximab Plus Heparin With Bivalirudin in Acute Coronary Syndrome
• CIPAMI-Study: Clopidogrel Administered Prehospital to Improve Primary PCI in Patients With Acute Myocardial Infarction
• Peri-Procedural Myocardial Infarction, Platelet Reactivity, Thrombin Generation, and Clot Strength: Differential Effects of Eptifibatide + Bivalirudin Versus Bivalirudin
• Effects of Recombinant Human Erythropoietin on Platelet Function in Patients With Acute Myocardial Infarction
• Intensive Insulin Therapy in Non-diabetic Patients With Acute Myocardial Infarction and Hyperglycaemia
• Safety Study of Bone Marrow Derived Cells to Treat Damaged Heart Muscle
• Randomized Multicenter Trial of Prehospital Initiated Facilitated Percutaneous Coronary Intervention (PCI) Versus Primary PCI in ST-segment-Elevation MI (STEMI)
• Efficacy Study on Early Versus Late Abciximab Administration During Primary Coronary Angioplasty
• WENBIT - Western Norway B Vitamin Intervention Trial
• Intravenous Isosorbide Dinitrate Versus Sublingual Isosorbide Dinitrate for the Relief of Acute Anginal Episodes in Acute Coronary Syndrome (ACS) Patients
• Efficacy of FX06 in the Prevention of Myocardial Reperfusion Injury
• Levosimendan in Acute Heart Failure Following Acute Myocardial Infarction.
• LV Thrombus Pilot Study for Comparing Enoxaparin Vs. Warfarin
• Half-Dose Intracoronary Abciximab Bolus Improves the Mortality Outcome Compared to Standard Intravenous Regimen
• Pilot Study of Hemoglobin Based Oxygen Therapeutics in Elective Coronary Revascularization
• Intra-coronary Infusion of Bone Marrow Derived Autologous CD34+ Selected Cells in Patients With Acute Myocardial Infarction
• Depiction of Delayed Enhancement in Patients With Documented Myocardial Infarction
• Myocardial Regeneration and Angiogenesis in Myocardial Infarction With G-CSF and Intra-Coronary Stem Cell Infusion
• A Clinical Trial to Demonstrate the Efficacy of Cangrelor
• Effect of Complementary Intracoronary Streptokinase Administration Immediately After Primary Percutaneous Coronary Intervention on Microvascular Perfusion and Late Term Infarct Size in Patients With Acute Myocardial Infarction
• Treating Acute MI Patients With Aggrastat on Their Way to Hospital
• Abciximab i.v. Versus i.c. in Primary PCI Patients With STEMI
• Myocardial Regeneration and Angiogenesis in Myocardial Infarction With G-CSF and Intra-Coronary Stem Cell Infusion-3-DES
• Myocardial Infarction Size Reduction With Atorvastatin
• Salvage: Postconditioning With Adenosine for STEMI
• Aspirin Dose and Atherosclerosis in Patients With Heart Disease
• A Study of INO-1001, an Intravenous PARP (Poly [ADP Ribose] Polymerase) Inhibitor in Acute Heart Attack Patients Undergoing Primary Percutaneous Coronary Intervention
• Bone Marrow Stem Cell Infusion Following a Heart Attack
• The Norwegian Vitamin Trial (NORVIT)
• Pilot Study of Edaravone to Treat Acute Myocardial Infarction
• Rural Andhra Pradesh Cardiovascular Prevention Study (RAPCAPS)
• Thrombolysis Versus Primary Angioplasty for AMI in Elderly Patients
• The Effect of GLP-1 on Glucose Uptake in the Brain and Heart in Healthy Men
• BELIEVE Study: Nesiritide and Post Myocardial Infarction Left Ventricular Modeling
• Safety and Efficacy Study of Eptifibatide in Primary Percutaneous Coronary Intervention (PCI)
• OMEGA-Study: Effect of Omega 3-Fatty Acids on the Reduction of Sudden Cardiac Death After Myocardial Infarction
• Female Sex is an Independent Predictor of Death and Bleeding Among Fibrinolytic Treated Patients With AMI
• Contrast Nephropathy Prevention With N-Acetylcysteine in Acute Myocardial Infarction
• Impact of Tight Glycaemic Control in Acute Myocardial Infarction
• Protective Effect of EPA on Cardiovascular Events
• Efficacy and Safety of Adding Clopidogrel to Aspirin or Use of Metoprolol in Myocardial Infarction
• Prevention of Cardiovascular Complications in Diabetic Patients With Vitamin E Treatment
• A Phase I - II Safety Study of Filgrastim (Neupogen) to Improve Left Ventricular Function After Severe Acute Myocardial Infarction
• Japan-Working Groups of Acute Myocardial Infarction for the Reduction of Necrotic Damage by ANP
• Japan-Working Groups of Acute Myocardial Infarction for the Reduction of Necrotic Damage by a K-ATP
• Assessment of an Alpha-glucosidase Inhibitor to Block Cardiac Events in Patients With MI and IGT
• Pioglitazone Protects Diabetes Mellitus (DM) Patients Against Re-Infarction (PPAR Study)
• Phase 1 Study of Potential Anti-Inflammatory Effects of Glucose Control During Acute Myocardial Infarction.
• IMPROVE-IT: Examining Outcomes in Subjects With Acute Coronary Syndrome: Vytorin (Ezetimibe/Simvastatin) vs Simvastatin (P04103)
• Hyperglycemia and Cardiovascular Outcomes With Type 2 Diabetes
• Bupropion for Hospitalized Smokers With Acute Cardiovascular Disease
• Pre-hospital Administration of Thrombolytic Therapy With Urgent Culprit Artery Revascularization
• Fluvastatin in the Therapy of Acute Coronary Syndrome
• A Trial Evaluating the Efficacy and Safety of Tenecteplase Together With Unfractionated Heparin Prior to Early Percutaneous Coronary Intervention (PCI) as Compared to Standard Primary PCI in Patients With Acute Myocardial Infarction (ASSENT 4 PCI)
• CARDIOLITE-413: A Study for Patients Who Had a PCI for an Acute MI
• Erythropoietin in Acute Myocardial Infarction
• Trial to Compare the Efficacy and Safety of a Single Bolus of TNK-tPA (Tenecteplase, Metalyse®) With Accelerated Infusion of Rt-PA (Alteplase, Actilyse®) in Asian Patients With Acute Myocardial Infarction
• Coronary Care Caffeine: Influence of Coffee on Heart Rate Post Myocardial Infarction
• Senior PAMI: Primary Angioplasty Versus Thrombolytic Therapy for Acute Myocardial Infarction in the Elderly
• Stem Cells in Myocardial Infarction
• Value of Abciximab in Patients With AMI Undergoing Primary PCI After Clopidogrel Pretreatment (BRAVE 3)
• Effects of Eplerenone on Left Ventricular Remodelling Following Heart Attack
• Nitroprusside for Prevention of no-Reflow in Primary Angioplasty
• Effects of Early Statin Treatment After Acute Myocardial Infarction (AMI) in Japanese Patients
• Bone Marrow Stem Cell Mobilisation Therapy for Acute Myocardial Infarction (AMI)(REVIVAL-2)
• Left Ventricular Function After Acute Myocardial Infarction (AMI). Treatment With Angiotensin 2-Receptor Blockade (GLOBAL-Study)
• Hexadecasaccharide (SR123781A) in Patients With Unstable Angina or Non-ST-Segment Elevation Myocardial Infarction
• Which Therapy for Acute Heart Attacks? (The WEST Study)
• Niacin Plus Statin to Prevent Vascular Events
• Electrophysiological Effects of Late PCI After MI
• Omega-3 Fatty Acids to Improve Depression and Reduce Cardiovascular Risk Factors
• Safety Study of Adult Mesenchymal Stem Cells (MSC) to Treat Acute Myocardial Infarction
• A Study of the Safety and Efficacy of Nitric Oxide Reduction in Patients With Cardiogenic Shock After a Heart Attack
• BRIEF-PCI: Brief Infusion of Eptifibatide Following Percutaneous Coronary Intervention
• HOPE-2 Study (Heart Outcomes Prevention Evaluation-2 Study)
• Safety of TG100-115 for Heart Attack Treated With Angioplasty
• Safety of KAI-9803 for Injection With Angioplasty Following Heart Attack
• Bivalirudin in Patients With Acute Myocardial Infarction (AMI) Undergoing Primary PCI
• Comparison of Angiomax Versus Heparin in Acute Coronary Syndromes (ACS)
• Insulin Resistance Intervention After Stroke Trial
• Pexelizumab in Conjunction With Angioplasty in Acute Myocardial Infarction (APEX-AMI)
• IMMEDIATE Trial - Out of Hospital Administration of Glucose, Insulin and Potassium.
• MCC-135 as Adjunct Therapy to Primary Percutaneous Coronary Intervention in ST-Segment Elevation Acute Myocardial Infarction Patients
• Enoxaparin and Thrombolysis Reperfusion for Acute Myocardial Infarction Treatment Thrombolysis in Myocardial Infarction - Study 25 (ExTRACT-TIMI25)
• Study of Oral PG-116800 Following a Heart Attack
• ARISE - Aggressive Reduction of Inflammation Stops Events
• OASIS-6 : The Safety and Efficacy of Fondaparinux Versus Control Therapy in Patients With ST Segment Elevation Acute Myocardial Infarction
• A Safety and Efficacy Trial Evaluating the Use of Fondaparinux in Percutaneous Coronary Intervention (PCI)(63133)(WITHDRAWN)
• MYOHEART™ (Myogenesis Heart Efficiency and Regeneration Trial)
• Vascular Interaction With Age in Myocardial Infarction
• Autologous Cultured Myoblasts (BioWhittaker) Transplanted Via Myocardial Injection
• A Study of Abciximab and Reteplase When Administered Prior to Catherization After a Myocardial Infarction (Finesse)
• SYNERGY: Open Study of Enoxaparin Versus Unfractionated Heparin in Patients With Acute Coronary Syndromes
• Warfarin Versus Aspirin in Reduced Cardiac Ejection Fraction (WARCEF) Trial
• Vitamin Therapy for Prevention of Stroke
• Occluded Artery Trial (OAT)
• The Role of Angiotensin Type I Receptor in the Regulation of Human Coronary Vascular Function
• The Role of Angiotensin Type I Receptor in the Regulation of Human Peripheral Vascular Function
• Azithromycin and Coronary Events Study (ACES)
• Magnesium in Coronaries (MAGIC)
• NHLBI Type II Coronary Intervention Study
• Prevention of Events With Angiotensin-Converting Enzyme Inhibitor Therapy (PEACE)
• Shock Trial: Should We Emergently Revascularize Occluded Coronaries for Cardiogenic Shock.
• Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)
• Women's Antioxidant and Folic Acid Cardiovascular Study (WAFACS)
• Cardiac Arrhythmia Suppression Trial (CAST)
• Intravenous Streptokinase in Acute Myocardial Infarction
• Thrombolysis in Myocardial Infarction (TIMI)
• Randomized Clinical Trial of Non-Surgical Reperfusion of the Coronary Arteries
• Multicenter Investigation of Limitation of Infarct Size (MILIS)
• Beta-Blocker Heart Attack Trial (BHAT)
• Aspirin-Myocardial Infarction Study (AMIS)
• Coronary Drug Project Mortality Surveillance
• Coronary Drug Project
• Women's Health Study (WHS): A Randomized Trial of Low-dose Aspirin and Vitamin E in the Primary Prevention of Cardiovascular Disease and Cancer
• Thrombolysis in Myocardial Ischemia Trial (TIMI III)
• Myocardial Infarction Triage and Intervention Project (MITI)
• Cardiac Arrest in Seattle: Conventional Versus Amiodarone Drug Evaluation (CASCADE)